Company intelligence / Profile preview
Guangzhou Jiayue Pharmaceutical Technology
- Ownership
- Private
- Development stage
- Other
Overview
Guangzhou Jiayue Pharmaceutical Technology is an active Chinese pharmaceutical company focused on the research and development of innovative small molecule drugs. Its pipeline includes late-stage clinical assets such as sufenidone for idiopathic pulmonary fibrosis (Phase 3), ERAS‑0015 targeting RAS-driven cancers (Phase 2), WXFL10030390 targeting PI3Ks/mTOR in STK11-mutant cancer (Phase 2), and JYP‑0061 for autoimmune diseases including atopic dermatitis and neuromyelitis optica. The company has also entered into notable licensing deals with international partners such as Erasca. Clinical results are not yet published for pivotal trials.
- Therapeutic areas
- NeurologyPulmonologyDermatologyOncologyImmunology
- Modalities
- Small moleculeMolecular glue
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Guangzhou Jiayue Pharmaceutical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangzhou Jiayue Pharmaceutical Technology.